Why the study?
Cancer therapy in children carries a risk of cardiotoxicity, necessitating methods beyond conventional echocardiography to detect subclinical myocardial dysfunction while ejection fraction is still preserved.
Does speckle tracking echocardiography improve the early detection of subclinical cardiotoxicity compared to conventional echocardiography in children treated for oncological diseases?
Does speckle tracking echocardiography improve the early detection of subclinical cardiotoxicity compared to conventional echocardiography in children treated for oncological diseases?
Speckle tracking echocardiography offers a promising non-invasive method for the early detection of subclinical cardiotoxicity in pediatric oncology patients.
Echocardiography should guide cardiotoxicity surveillance in childhood cancer survivors; leaves open optimal long-term screening protocols.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Miroslava Burešová (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: